A growing number of ketamine clinics and therapists in the US and Canada are offering ketamine therapy to help patients treat a variety of mental health conditions such as depression, PTSD, anxiety and more.
To better understand what ketamine therapy looks like across North America, Wavepaths Strategic Account Manager, Antonia Mills, is travelling from coast to coast to visit ketamine clinics and therapists in the US and Canada.
Travelling to 14 different destinations from east to west coast, Antonia is currently amidst a six week tour – the 1st ever Wavepaths tour of ketamine clinics across North America – to learn more from each unique practice and person she meets.
“This is one of the first times we have sent our team from the UK to meet our subscribers, partners and psychedelic therapists in person,” said Antonia, Strategic Account Manager, Wavepaths. “So far what has surprised me is how each clinic has its own unique way of care and completely different approaches to set, setting and personalization. I’m looking forward to learning more and meeting new people over the next several stops on my tour.”
Throughout her tour, Antonia is:
- meeting with clinic owners
- speaking with therapists
- listening to patient stories
- watching how therapists account for set and setting in their practice, and
- sharing her learnings back with the Wavepaths community.
Ketamine Clinics in Canada
Ketamine Clinics in the US
The Rise and Growth of Ketamine Therapy
Ketamine therapy, a type of psychedelic-assisted therapy, is growing in use for treating mental health conditions like: depression, anxiety, PTSD, and addiction.
In the US and Canada, ketamine is a legal psychedelic drug for use in therapeutic settings.
Ketamine is a medication that is FDA approved, and has been used for decades in surgery. Over time, a growing body of research has identified the transformative effects ketamine can have on the brain and ketamine has been repurposed (in lower doses than used in anaesthesia) as a legal method for psychedelic for therapy.
In comparison to traditional antidepressants, ketamine affects a larger number of neurotransmitters in the brain.
According to Dr. Sara Herman, board-certified anesthesiologist and founder of Soft Reboot Wellness:
“At low doses, ketamine boosts production of glutamate and BDNF, a vital protein. When this happens, some people may have vibrant daydreams or a magical feeling of the mind separating from the body. Throughout this transcendent experience, ketamine is working hard to build new, stronger, healthier connections—or synapses—between brain cells. More synaptic communication translates to better brain health and mood regulation.”
Source: Dr. Sara Herman, Soft Reboot Wellness.
Interest in psychedelic therapy is growing, and with it, an expanding number of clinics offering ketamine therapy are opening up across the world. As the need for more effective treatment options for mental health increases, promising approaches like psychedelic therapy are becoming more prevalent.
As the field of ketamine therapy continues to grow, continued research into best practices, clinical approaches and therapeutic settings is critical to delivering safe and effective patient experiences.
Wavepaths is committed to supporting therapists in deepening their practice, while helping patients experience person-centred care. Through touring ketamine clinics across North America, Wavepaths hopes to gain a better understanding of best practices, effective therapeutic methods and where care providers can be supported in using music for psychedelic therapy.